S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Lixte Biotechnology Pivots to Energy Storage Amid Stock Slide

Shares of Lixte Biotechnology tumbled 12% to $6.41 during Friday trading after the cancer-drug developer unveiled plans to pivot into the energy sector. The company intends to acquire Nomad Transportable Power Systems and rebrand itself as Nomad Power Solutions, marking a sharp departure from its historical pharmaceutical focus.

Lixte Biotechnology Pivots to Energy Storage Amid Stock Slide

This strategic shift began June 1, when Lixte announced its intent to transform into an AI-driven energy infrastructure business. While the company is currently seeking a partner to offload its existing medical technology and drug development assets, investors reacted skeptically to the transition. The stock remains up 63% for the year despite the recent sell-off.

Lixte has not disclosed the financial terms of the Nomad acquisition. The target company, which specializes in mobile utility-grade battery storage, reported a 175% revenue increase in 2025. Lixte emphasizes that Nomad’s mobile systems provide a logistical advantage over traditional, permanent battery energy storage projects, which often face development delays spanning two to five years.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!